Editorial: Precision medicine for acute myeloid leukemia.
作者信息
Marconi Giovanni, Guolo Fabio, Nanni Jacopo, Papayannidis Cristina
机构信息
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Chair of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy.
出版信息
Front Oncol. 2023 Jul 25;13:1233757. doi: 10.3389/fonc.2023.1233757. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Precision medicine for acute myeloid leukemia.社论：急性髓系白血病的精准医学
Front Oncol. 2023 Jul 25;13:1233757. doi: 10.3389/fonc.2023.1233757. eCollection 2023.
2
Precision medicine for acute myeloid leukemia.急性髓系白血病的精准医学
Expert Rev Hematol. 2016 Jan;9(1):1-3. doi: 10.1586/17474086.2016.1107471. Epub 2015 Oct 30.
3
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?为急性白血病精准医疗而努力：我们是否已经到达？
Pharmacotherapy. 2017 Sep;37(9):1052-1072. doi: 10.1002/phar.1977. Epub 2017 Jul 31.
4
Treatment of acute myeloid leukemia in the next decade - Towards real-time functional testing and personalized medicine.未来十年急性髓细胞白血病的治疗——迈向实时功能检测和个性化医疗。
Blood Rev. 2017 Nov;31(6):418-425. doi: 10.1016/j.blre.2017.08.001. Epub 2017 Aug 4.
5
Precision medicine in myeloid malignancies.髓系恶性肿瘤的精准医学。
Semin Cancer Biol. 2022 Sep;84:153-169. doi: 10.1016/j.semcancer.2021.03.034. Epub 2021 Apr 22.
6
Personalized therapy for acute myeloid leukemia.急性髓系白血病的个性化治疗
Cancer Discov. 2013 Dec;3(12):1336-8. doi: 10.1158/2159-8290.CD-13-0832.
7
Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?急性髓系白血病中的精准医学：我们目前所处的位置以及未来的发展方向？
Expert Rev Hematol. 2020 Oct;13(10):1057-1065. doi: 10.1080/17474086.2020.1818559. Epub 2020 Sep 17.
8
Future perspective: metabolism as a therapeutic target in acute myeloid leukemia - from Warburg to precision medicine.未来展望：代谢作为急性髓系白血病的治疗靶点——从瓦伯格效应到精准医学
Curr Med Res Opin. 2021 Dec;37(12):2107-2111. doi: 10.1080/03007995.2021.1978960. Epub 2021 Sep 23.
9
Long noncoding RNAs to predict survival in acute myeloid leukemia: a step toward personalized medicine?长链非编码RNA预测急性髓系白血病的生存：迈向个性化医疗的一步？
Biomark Med. 2016 Sep;10(9):935-8. doi: 10.2217/bmm-2016-0173. Epub 2016 Aug 22.
10
[Precision genomic and translational medicine for acute myeloid leukemia].[急性髓系白血病的精准基因组与转化医学]
Yi Chuan. 2018 Nov 20;40(11):988-997. doi: 10.16288/j.yczz.18-188.
本文引用的文献
1
Biological therapy in elderly patients with acute myeloid leukemia.老年急性髓系白血病患者的生物治疗。
Expert Opin Biol Ther. 2023 Feb;23(2):175-194. doi: 10.1080/14712598.2023.2174015. Epub 2023 Feb 14.
2
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.维奈托克联合 FLAG-IDA 诱导和巩固治疗新诊断和复发/难治性急性髓系白血病。
J Clin Oncol. 2021 Sep 1;39(25):2768-2778. doi: 10.1200/JCO.20.03736. Epub 2021 May 27.
3
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.阿扎胞苷和维奈托克治疗未经治急性髓系白血病。
N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.
4
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.老年急性髓系白血病化疗与 Venetoclax 试验（CAVEAT）：Venetoclax 联合改良强化化疗的 1b 期剂量递增研究。
J Clin Oncol. 2020 Oct 20;38(30):3506-3517. doi: 10.1200/JCO.20.00572. Epub 2020 Jul 20.
5
Genomic Classification and Prognosis in Acute Myeloid Leukemia.急性髓系白血病的基因组分类与预后
N Engl J Med. 2016 Jun 9;374(23):2209-2221. doi: 10.1056/NEJMoa1516192.
6
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.在英国医学研究理事会试验中治疗的 5876 例年轻成年患者中，对罕见重现染色体异常进行细胞遗传学分类的细化：确定其预后意义。
Blood. 2010 Jul 22;116(3):354-65. doi: 10.1182/blood-2009-11-254441. Epub 2010 Apr 12.
Zotero 插件